| Literature DB >> 19381251 |
Yixin H Ye1, Stephen F Chenoweth, Elizabeth A McGraw.
Abstract
Drosophila harbor substantial genetic variation for antibacterial defense, and investment in immunity is thought to involve a costly trade-off with life history traits, including development, life span, and reproduction. To understand the way in which insects invest in fighting bacterial infection, we selected for survival following systemic infection with the opportunistic pathogen Pseudomonas aeruginosa in wild-caught Drosophila melanogaster over 10 generations. We then examined genome-wide changes in expression in the selected flies relative to unselected controls, both of which had been infected with the pathogen. This powerful combination of techniques allowed us to specifically identify the genetic basis of the evolved immune response. In response to selection, population-level survivorship to infection increased from 15% to 70%. The evolved capacity for defense was costly, however, as evidenced by reduced longevity and larval viability and a rapid loss of the trait once selection pressure was removed. Counter to expectation, we observed more rapid developmental rates in the selected flies. Selection-associated changes in expression of genes with dual involvement in developmental and immune pathways suggest pleiotropy as a possible mechanism for the positive correlation. We also found that both the Toll and the Imd pathways work synergistically to limit infectivity and that cellular immunity plays a more critical role in overcoming P. aeruginosa infection than previously reported. This work reveals novel pathways by which Drosophila can survive infection with a virulent pathogen that may be rare in wild populations, however, due to their cost.Entities:
Mesh:
Year: 2009 PMID: 19381251 PMCID: PMC2663048 DOI: 10.1371/journal.ppat.1000385
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Figure 1Average percentage survival of flies (male and female) at 48 hours post-infection of controls (open symbols) and lines selected for PA01 defense (solid symbols).
Survival was measured for every generation for selected lines and at G6 and G10 for control lines. Selection was halted at G10 before defense was assessed again at G15.
Figure 2Life-history traits of control (open bars) and selected (black bars) lines measured at G9.
Line means are plotted±sem. * P-value<0.05, ** P-value<0.01, *** P-value<0.001.
Figure 3Venn diagram of number of transcripts that show significant expression changes (up-regulated/down-regulated) across the three lines.
Fold change of up-regulated immune genes in selected lines compared to respective controls.
| Flybase Gene ID | NAME | Microarrays | qPCR validation | |||||
| S1 | S2 | S3 | S1 | S2 | S3 | |||
|
| ||||||||
| PGRP | ||||||||
| FBgn0043578 | PGRP-SB1 | 1.98 | 2.01 | 2.19 | ||||
| FBgn0035806 | PGRP-SD | 1.71 | 1.96 | 1.67 | 1.68 | 2.05 | 1.56 | |
| FBgn0043575 | PGRP-SC2 | 1.81 | 1.76 | |||||
| Antimicrobial peptides | ||||||||
| FBgn0052282 | drosomycin-4 | 1.71 | 1.49 | 1.40 | 1.24 | 1.64 | 1.25 | |
| FBgn0035434 | drosomycin-5 | 1.53 | 1.48 | 1.39 | ||||
| FBgn0034407 | Diptericin B | 2.02 | 1.77 | 1.90 | ||||
| Toll pathway | ||||||||
| FBgn0030926 | Persephone | 1.48 | 1.66 | 1.36 | ||||
| FBgn0000533 | Easter | 1.24 | 1.24 | 1.23 | ||||
|
| ||||||||
| Recognition and phagocytosis | ||||||||
| FBgn0014033 | Scavenger receptor class C, type I | 2.46 | 1.74 | 1.94 | 1.86 | 1.30 | 1.52 | |
| FBgn0041182 | Tep II | 2.13 | 1.39 | 2.06 | 1.38 | 1.15 | 1.36 | |
| FBgn0028545 | nimC1 | 1.84 | 1.96 | 1.60 | ||||
| FBgn0039484 | Eater | 1.92 | 2.02 | 1.83 | 1.80 | 1.88 | 2.09 | |
| FBgn0027562 | CG10345 | 1.57 | 1.16 | |||||
| FBgn0035090 | CG2736 | 1.90 | 1.24 | |||||
| FBgn0041183 | Tep I | 4.96 | 1.54 | |||||
| FBgn0043792 | CG30427 | 1.19 | 1.57 | 1.48 | ||||
| FBgn0039687 | CG7593 | 1.33 | 1.14 | |||||
| FBgn0035993 | CG3891 | 2.64 | 1.60 | 1.87 | ||||
| Melanization and coagulation | ||||||||
| FBgn0033367 | CG8193 | 1.51 | 1.32 | 1.32 | ||||
| FBgn0000165 | Black cells | 2.70 | 1.96 | 1.99 | 1.99 | 1.46 | 1.51 | |
*: P-value<0.05.
**: P-value<0.01.
***: P-value<0.001.
For cases where multiple transcripts are present for the same gene, an average was taken. qPCR validation of 6 genes is shown next to the microarrays data.
A comparison of the number of genes involved in humoral and cellular immunity upon infection from various microarrays studies.
| Reference | Bacterial strain | Humoral (#genes) | Cellular (#gene) | Humoral/Cellular (ratio of #) | |||||
| AMP | PGRP | Toll/Imd | Sum | Recognition/Phagocytosis | melanization/coagulation | Sum | |||
|
|
| 15 | 7 | 9 |
| 2 | 9 |
|
|
|
|
| 15 | 5 | 5 |
| 1 | 0 |
|
|
|
|
| 13 | 1 | 2 |
| 2 | 0 |
|
|
| This study |
| 3 | 3 | 2 |
| 10 | 2 |
|
|
*: based on genes with shared expression in 2/3 lines.
Primers for quantitative real-time PCR.
| Gene name | FlyBase ID | Forward Primer (′5′-3′) | Reverse Primer (′5′-3′) | Product size |
| rpS17 | FBgn0005533 |
|
| 81 |
| PGRP-SD | FBtr0076807 |
|
| 198 |
| Thiolester containing protein II | FBtr0079510 |
|
| 184 |
| eater | FBtr0085134 |
|
| 190 |
| Black cells | FBtr0086819 |
|
| 196 |
| Drosomycin-4 | FBtr0073061 |
|
| 151 |
| Scavenger receptor C, type I | FBtr0077467 |
|
| 171 |